Display Settings:

Format

Send to:

Choose Destination
    Brain Res. 2002 Jun 14;940(1-2):102-4.

    Serum S-100beta as a possible marker of blood-brain barrier disruption.

    Source

    Department of Neurological Surgery, Cleveland Clinic Foundation NB-20, 9500 Euclid Avenue, NB2-137, Cleveland, OH 44195, USA.

    Abstract

    Two brain-specific proteins, S-100beta and neuron-specific enolase (NSE), are released systemically after cerebral lesions, but S-100beta levels sometimes rise in the absence of neuronal damage. We hypothesized that S-100beta is a marker of blood-brain barrier (BBB) leakage rather than of neuronal damage. We measured both proteins in the plasma of patients undergoing iatrogenic BBB disruption with mannitol, followed by chemotherapy. Serum S-100beta increased significantly after mannitol infusion (P<0.05) while NSE did not. This suggests that S-100beta is an early marker of BBB opening that is not necessarily related to neuronal damage.

    PMID:
    12020881
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk